OKYO Pharma Ltd (LSE:OKYO) - Share price


Stock Report

OKYO Pharma Ltd OKYO

Last Price
GBX4.45

Day Change
-2.05|-31.54%

As of 18/05/2022
17:02:26 BST | GBX
Minimum 15 Minutes Delay.

Last Close6.50p
Day Range4.40 - 6.13
Mkt Cap89.34Mil
52-Wk Range4.00 - 9.00
Yield %-
ISINGG00BD3FV870
Volume2,307,589
P/E-
P/S
P/CF-0.24

Share Price

Total Returns 17/05/2022

 Chg (%)  
More ...
OKYO Pharma Ltd6.12 
FTSE 100 TR GBP-1.00
 
Financials
201920202021
More ...
Income Statement
Turnover-0.000.00
Operating Profit-3.48-1.21-3.01
Net Profit-3.76-1.21-3.00
Reported EPS-1.00-0.20-0.45
Balance Sheet
Current Assets0.580.465.06
Non Current Assets0.000.030.08
Total Assets0.580.485.14
Current Liabilities0.330.581.24
Total Liabilities0.330.601.28
Total Equity0.26-0.113.85
Cash Flow
Operating Cash Flow-1.53-0.96-1.31
Net Change in Cash-1.53-0.294.80

Company Profile

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Sector

Biotechnology

Index

Next Event 02/08/2022

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-77.31
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Gabriele Marco Antonio Cerrone
Non-Executive Director, Senior Independent DirectorMr. Willy Jules Simon
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.